tiprankstipranks
Trending News
More News >
Kindstar Globalgene Technology, Inc. (HK:9960)
:9960
Hong Kong Market

Kindstar Globalgene Technology, Inc. (9960) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Kindstar Globalgene Technology, Inc. has a market cap or net worth of HK$1.43B. The enterprise value is HK$1.22B.
Market CapHK$1.43B
Enterprise ValueHK$1.22B

Share Statistics

Kindstar Globalgene Technology, Inc. has 1,040,758,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,040,758,400
Owned by Insiders
Owned by Institutions

Financial Efficiency

Kindstar Globalgene Technology, Inc.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -1.63%.
Return on Equity (ROE)-0.02
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-1.63%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee308.06K
Profits Per Employee-18.66K
Employee Count3,011
Asset Turnover0.25
Inventory Turnover9.48

Valuation Ratios

The current PE Ratio of Kindstar Globalgene Technology, Inc. is -19.21. Kindstar Globalgene Technology, Inc.’s PEG ratio is 0.17.
PE Ratio-19.21
PS Ratio0.00
PB Ratio0.40
Price to Fair Value0.38
Price to FCF-7.30
Price to Operating Cash Flow-16.05
PEG Ratio0.17

Income Statement

In the last 12 months, Kindstar Globalgene Technology, Inc. had revenue of 927.57M and earned -54.59M in profits. Earnings per share was -0.06.
Revenue927.57M
Gross Profit439.56M
Operating Income-48.67M
Pretax Income-56.19M
Net Income-54.59M
EBITDA-115.25M
Earnings Per Share (EPS)-0.06

Cash Flow

In the last 12 months, operating cash flow was -70.25M and capital expenditures -95.22M, giving a free cash flow of -165.47M billion.
Operating Cash Flow-70.25M
Free Cash Flow-165.47M
Free Cash Flow per Share-0.16

Dividends & Yields

Kindstar Globalgene Technology, Inc. pays an annual dividend of HK$0.024, resulting in a dividend yield of 1.76%
Dividend Per ShareHK$0.024
Dividend Yield1.76%
Payout Ratio-36.09%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.52
52-Week Price Change-1.44%
50-Day Moving Average1.33
200-Day Moving Average1.23
Relative Strength Index (RSI)54.29
Average Volume (3m)1.02M

Important Dates

Kindstar Globalgene Technology, Inc. upcoming earnings date is Sep 2, 2025, TBA (Confirmed).
Last Earnings DateMar 28, 2025
Next Earnings DateSep 2, 2025
Ex-Dividend DateJun 09, 2025

Financial Position

Kindstar Globalgene Technology, Inc. as a current ratio of 2.63, with Debt / Equity ratio of 14.31%
Current Ratio2.63
Quick Ratio2.57
Debt to Market Cap0.34
Net Debt to EBITDA-0.15
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Kindstar Globalgene Technology, Inc. has paid 4.49M in taxes.
Income Tax4.49M
Effective Tax Rate-0.08

Enterprise Valuation

Kindstar Globalgene Technology, Inc. EV to EBITDA ratio is -9.24, with an EV/FCF ratio of 0.00.
EV to Sales1.15
EV to EBITDA-9.24
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00

Balance Sheet

Kindstar Globalgene Technology, Inc. has HK$1.66B in cash and marketable securities with ¥398.36M in debt, giving a net cash position of -HK$1.26B billion.
Cash & Marketable SecuritiesHK$1.66B
Total Debt¥398.36M
Net Cash-HK$1.26B
Net Cash Per Share-HK$1.21
Tangible Book Value Per ShareHK$2.94

Margins

Gross margin is 47.39%, with operating margin of -5.25%, and net profit margin of -5.89%.
Gross Margin47.39%
Operating Margin-5.25%
Pretax Margin-6.06%
Net Profit Margin-5.89%
EBITDA Margin-12.42%
EBIT Margin-4.86%

Analyst Forecast

The average price target for Kindstar Globalgene Technology, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast-6.00%
EPS Growth Forecast-232.11%

Scores

Smart Score5
AI Score45
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis